Howard Wealth Management’s VanEck Biotech ETF BBH Stock Holding History

Howard Wealth Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$246K	Hold	1,006	–	–	0.09%	133
2026 Q2	$204K	Buy	+1,006	New	+$189K	0.08%	152
2024 Q2	–	Sell	-1,218	Closed	-$203K	–	94
2024 Q1	$203K	Hold	1,218	–	–	0.16%	101
2023 Q4	$201K	Buy	+1,218	New	+$187K	0.17%	99
2023 Q1	–	Sell	-1,398	Closed	-$223K	–	110
2022 Q4	$223K	Buy	+1,398	New	+$221K	0.18%	100
2022 Q3	–	Sell	-1,398	Closed	-$203K	–	115
2022 Q2	$203K	Buy	1,398 +30	+2%	+$4.47K	0.22%	58
2022 Q1	$221K	Buy	1,368 +236	+21%	+$38.2K	0.12%	122
2021 Q4	$214K	Buy	1,132 +68	+6%	+$13.1K	0.11%	125
2021 Q3	$215K	Hold	1,064	–	–	0.12%	118
2021 Q2	$214K	Buy	+1,064	New	+$198K	0.12%	123
2020 Q1	–	Sell	-1,014	Closed	-$141K	–	133
2019 Q4	$141K	Buy	+1,014	New	+$133K	0.12%	114

Other funds holding BBH

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Miller Investment Management West Conshohocken, Pennsylvania $1.13B AUM 13.3% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Conservest Capital Advisors Wynnewood, Pennsylvania $1.28B AUM 17.34% 1-Year Est. Return

Paragon Private Wealth Management Lexington, Kentucky $326M AUM 26.55% 1-Year Est. Return

Bleakley Financial Group Fairfield, New Jersey $8.8B AUM 22.37% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Rockefeller Capital Management New York $68.5B AUM 24.33% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $121B AUM 21.47% 1-Year Est. Return

Howard Wealth Management's BBH Position: Q3 2026 in Review

Howard Wealth Management held its VanEck Biotech ETF (BBH) position steady in Q3 2026 at 1,006 shares worth $246K. The position accounts for 0.09% of the portfolio, ranked #133.

Howard Wealth Management first reported a position in BBH in Q4 2019 and has held it in 11 quarters since. 103 funds tracked by Wall St. Rank hold BBH as of Q3 2026.

Howard Wealth Management held 1,006 shares of VanEck Biotech ETF worth $246K as of Q3 2026.
Howard Wealth Management left its VanEck Biotech ETF share count unchanged in Q3 2026.
VanEck Biotech ETF made up 0.09% of Howard Wealth Management's portfolio in Q3 2026, its #133 holding.
Howard Wealth Management first reported a position in VanEck Biotech ETF in Q4 2019 and has held it in 11 quarters since.
103 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2026.

Based on Howard Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.